Rosai dorfman disease of the orbit
Rosai dorfman disease of the orbit
| dc.contributor.author | Vemuganti, Geeta K. | |
| dc.contributor.author | Naik, Milind N. | |
| dc.contributor.author | Honavar, Santosh G. | |
| dc.date.accessioned | 2022-03-27T04:10:46Z | |
| dc.date.available | 2022-03-27T04:10:46Z | |
| dc.date.issued | 2008-12-01 | |
| dc.description.abstract | Objective: To report the clinico-histopathologic features, management and outcome of RosaiDorfman disease of the orbit. Design: Non-comparative case series. Results: Rosai-Dorfman disease of the orbit constituted 0.09% of all ocular specimens received at our Institute, presenting with a firm rubbery mass causing proptosis; bilateral in 4 (57%) cases. The median age at presentation was 13 years (range 5-65); median duration of symptoms was 6 (range 3-15) years. Lymphadenopathy was noted in 4 (57%); extranodal involvement in 3 (43%). After biopsy, 3 cases were treated with systemic corticosteroids, 2 cases developed local recurrence that responded to systemic corticosteroid therapy. Polymorphous population of lymphocytes, plasma cells, and characteristic S-100-positive histiocytes showing emperipolesis were pathognomonic histologic features. Conclusion: Rosai-Dorfman disease of the orbit, although rare, should be considered in young individuals with chronic proptosis with rubbery masses. Excision and corticosteroid therapy provide a favorable outcome. © 2008 Vemuganti et al. | |
| dc.identifier.citation | Journal of Hematology and Oncology. v.1(1) | |
| dc.identifier.uri | 10.1186/1756-8722-1-7 | |
| dc.identifier.uri | https://jhoonline.biomedcentral.com/articles/10.1186/1756-8722-1-7 | |
| dc.identifier.uri | https://dspace.uohyd.ac.in/handle/1/6579 | |
| dc.title | Rosai dorfman disease of the orbit | |
| dc.type | Journal. Article | |
| dspace.entity.type |
Files
License bundle
1 - 1 of 1